Mert Giray Ilhan

What drives success in biopharma?

For over a decade, I’ve worked as a strategy and M&A professional, advising C-suite executives on high-stakes decisions in strategy, innovation, M&A, and investment across the biopharmaceutical industry.

I write a weekly newsletter and occasional essays on the developments that matter—tailored specifically for biopharma executives and investors.

Follow me on X or LinkedIn, or get in touch via email.